Literature DB >> 20427051

Phosphatidylinositol-3-kinase-AKT pathway, phospho-JUN and phospho-JNK expression in spontaneously arising bovine urinary bladder tumours.

A Corteggio1, C Urraro, S Roperto, F Roperto, G Borzacchiello.   

Abstract

The aetiopathogenesis of urinary bladder tumours in cattle involves prolonged ingestion of bracken fern and infection by bovine papillomavirus types 1 or 2 (BPV-1/2). E5, the major BPV-1/2 oncoprotein, binds to the activated platelet-derived growth factor beta receptor (pPDGF-betaR), inducing cell transformation in vitro and spontaneously arising urinary bladder tumours. The aim of this study was to assess whether the 85 kDa regulatory subunit (p85) of the phosphatidylinositol-3-kinase (PI3K)-AKT pathway and other transforming signals phospho-JUN (pJUN) and phospho-JUN N-terminal kinases (pJNK) may be important in the development of BPV-associated urothelial carcinomas. A physical interaction between the pPDGF-betaR and PI3K was shown in four tumours and two samples of normal bladder tissue by co-immunoprecipitation and western blotting. There was greater expression of the PI3K-AKT-cyclin D3 molecular pathway downstream to the activation of pPDGF-betaR in neoplastic compared with normal tissue. pJNK and pJUN were overexpressed in samples of tumour compared with normal mucosal tissue. These findings provide new insights into the aetiopathogenic mechanisms underlying naturally occurring bovine urothelial carcinogenesis and contribute to understanding of the role of E5 oncoprotein in naturally occurring tumorigenesis. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427051     DOI: 10.1016/j.jcpa.2010.03.001

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  7 in total

1.  Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.

Authors:  Dalsu Baris; Richard Waddell; Laura E Beane Freeman; Molly Schwenn; Joanne S Colt; Joseph D Ayotte; Mary H Ward; John Nuckols; Alan Schned; Brian Jackson; Castine Clerkin; Nathaniel Rothman; Lee E Moore; Anne Taylor; Gilpin Robinson; Gm Monawar Hosain; Karla R Armenti; Richard McCoy; Claudine Samanic; Robert N Hoover; Joseph F Fraumeni; Alison Johnson; Margaret R Karagas; Debra T Silverman
Journal:  J Natl Cancer Inst       Date:  2016-05-02       Impact factor: 13.506

Review 2.  The E5 proteins.

Authors:  Daniel DiMaio; Lisa M Petti
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 3.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

Review 4.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

Review 5.  Role of the JNK Pathway in Bladder Cancer.

Authors:  Eun Hye Lee; Hyun Tae Kim; So Young Chun; Jae-Wook Chung; Seock Hwan Choi; Jun Nyung Lee; Bum Soo Kim; Eun Sang Yoo; Tae Gyun Kwon; Tae-Hwan Kim; Yun-Sok Ha
Journal:  Onco Targets Ther       Date:  2022-09-05       Impact factor: 4.345

6.  Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one?

Authors:  Annunziata Corteggio; Gennaro Altamura; Franco Roperto; Giuseppe Borzacchiello
Journal:  Infect Agent Cancer       Date:  2013-01-09       Impact factor: 2.965

7.  RBM39 Alters Phosphorylation of c-Jun and Binds to Viral RNA to Promote PRRSV Proliferation.

Authors:  Yinna Song; Yanyu Guo; Xiaoyang Li; Ruiqi Sun; Min Zhu; Jingxuan Shi; Zheng Tan; Lilin Zhang; Jinhai Huang
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.